euHCVdb logo

Table 2. Listing of HCV Variants With Proposed Changes in Genotype Nomenclature (Simmonds P, et al., 2005)


Proposed Designation* Published Designation Status** Isolate*** Region Sequenced**** Reference(s)

Genotype 2
   2k 2j C RU169 NS5B (D86532),
3'UTR (D86532)
Tokita H, et al.(1998)
   2j 2l P BA047 NS5B (D86530),
3'UTR (D86530)
Tokita H, et al.(1998)
   2n 2e P NL50 C/E1 (L39309),
NS5B (L44602)
Stuyver L, et al.(1995)
   2o 4f/2f P FR4 C/E1 (L38333),
NS5B (L38373)
Stuyver L, et al.(1995)
   2p 2f P NL33 C/E1, (L39300),
BS5B (L44601)
Stuyver L, et al.(1995)
   2q 2k P BA045 NS5B (D86529),
3'UTR (D86529)
Tokita H, et al.(1998)
Genotype 3
   3k 10a C HPCJK049E1 Complete genome (D63821) Tokita H, et al.(1996)
Genotype 4
   4r 4a P Z4 C/E1 (U10236 /L16652) Bukh J, et al.(1993) ,
Bukh J, et al.(1994)
FrSSD120 C/E1 (AJ401097) ,
NS5B (AJ291282)
Morice Y, et al.(2001)
   4n 4 alfa P 1359 C/E1 (AF271874) Ray SC, et al.(2000)
   4o 4 beta P 2153 C/E1 (AF271882),
NS5B (AF271815)
Ray SC, et al.(2000)
Genotype 6
   6c 7d P Th846 C/E1 (D37843),
NS5B (D37857)
Tokita H, et al.(1995)
   6d 7b C VN235 Complete genome (D84263) Tokita H, et al.(1998)
   6e 7a P VN540 C/E1 (D88474),
NS5B (D87361)
Tokita H, et al.(1994)
   6f 7e P BB7 NS5B (D28541) Apichartpiyakul C, et al.(1994)
   6f 7c P Th271 C/E1 (D37844),
NS5B (D37858)
Tokita H, et al.(1995)
   6g 11a C HPCJK046E Complete genome (D63822) Tokita H, et al.(1996)
   6h 9a C VN004 Complete genome (D84265) Tokita H, et al.(1998)
   6i 9b P Th555 C/E1 (D37849),
NS5B (D37863)
Tokita H, et al.(1995)
   6j 9c P Th553 C/E1 (D37848),
NS5B (D37862)
Tokita H, et al.(1995)
   6k 8b C VN405 Complete genome (D84264) Tokita H, et al.(1994)
   6l 8a P VN507 C/E1 (D88470),
NS5B (D87357)
Tokita H, et al.(1994)

  *  Proposed new name based on revised criteria for genotype designations.
  **  Classification status; C: Confirmed; P: Provisional.
  ***  Example of isolates referred to in associated publications (last column).
  ****  Regions sequenced (accession numbers in parentheses), prioritized for (1) complete genome; (2) Core/E1 and NS5B regions; (3) other regions where core/E1 and NS5B regions are not both available.